A single dose of the SARS-CoV-2 vaccine candidate stimulates a neutralization response in COVID-19 convalescents
Mutant peptides derived from SARS-CoV-2 inhibit the ability of T cells to recognize and destroy infectious cells
Studies suggest that there is no protection against SARS-CoV-2 infections from recent exposure to HCoVs